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Phosphoinositide-dependent kinase l (PDK1) phosphory-
lates and activates multiple AGC serine kinases, including
protein kinase B (PKB), p70Ribosomal S6 kinase (S6K)
and p90Ribosomal S6 kinase (RSK). PDK1 is required for
thymocyte differentiation and proliferation, and herein,
we explore the molecular basis for these essential func-
tions of PDK1 in T lymphocyte development. A key finding
is that PDK1 is required for the expression of key nutrient
receptors in T cell progenitors: CD71 the transferrin re-
ceptor and CD98 a subunit of L-amino acid transporters.
PDK1 is also essential for Notch-mediated trophic and
proliferative responses in thymocytes. A PDK1 mutant
PDK1 L155E, which supports activation of PKB but no
other AGC kinases, can restore CD71 and CD98 expression
in pre-T cells and restore thymocyte differentiation.
However, PDK1 L155E is insufficient for thymocyte pro-
liferation. The role of PDK1 in thymus development thus
extends beyond its ability to regulate PKB. In addition,
PDK1 phosphorylation of AGC kinases such as S6K and
RSK is also necessary for thymocyte development.
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Introduction
T cell development in the thymus produces peripheral T cells
with a useful repertoire of Tcell antigen receptors (TCRs) and
is coordinated by extracellular signals from antigen receptors,
cytokines and stromal cells. These stimuli link via tyrosine
kinases to a diverse network of GTPases and serine kinases.
The importance of serine kinases for thymocyte development
is revealed by studies of phosphoinositide-dependent kinase l
(PDK1), a kinase that phosphorylates a key ‘T’ loop site
within the catalytic domain of AGC serine kinases (Hinton
et al, 2004). PDK1 phosphorylates and activates multiple AGC
kinases, including phosphatidyl inositol-3 kinase (PI3K)-con-
trolled serine kinases such as Akt or protein kinase B (PKB),
the 70-kDa ribosomal S6 kinase-1 (S6K1) and the 90-kDa
ribosomal S6 kinase (RSK). Deletion of PDK1 in T cell
progenitors causes a block in T cell development (Hinton
et al, 2004). PDK1-deficient thymocytes fail to differentiate
past the pre-T cell stage and do not make peripheral T cells.
The TCR has variable a/b subunits that recognise peptide/
MHC complexes and the selection of cells that have success-
fully rearranged their TCRb gene locus is an essential step in
T cell development (von Boehmer et al, 1999; Michie and
Zuniga-Pflucker, 2002). This occurs in T cell precursors,
which do not express the major histocompatibility complex
(MHC) receptors CD4 and CD8 (double-negative (DN) thy-
mocytes). T cell progenitors initiate rearrangements of the
TCRb locus and if successful produce a TCRb chain that
permits surface expression of the pre-TCR complex compris-
ing TCRb, pre-Ta and CD3 antigens. The pre-TCR, in combi-
nation with Notch, then induces proliferation and
differentiation into CD4/CD8 double-positive (DP) thymo-
cytes (Wolfer et al, 2002; Maillard et al, 2003; Ciofani et al,
2004; Schmitt et al, 2004a; Tanigaki et al, 2004; Ciofani and
Zuniga-Pflucker, 2005; Laky et al, 2006). The process is
referred to as b-selection, because only cells that have
successfully rearranged their TCRb locus undergo prolifera-
tive expansion and differentiate to DPs.
The pre-TCR activates PDK1-regulated kinases (Hinton
et al, 2006; Mao et al, 2007) and these are clearly essential
for thymocyte development as PDK1-null pre-T cells do not
proliferate or differentiate yet express TCRb subunits and
have a functioning pre-TCR (Hinton et al, 2004). Loss of
PDK1 causes a size reduction of b-selected pre-T cells indi-
cative of a metabolic defect (Hinton et al, 2004). In this
context, Notch signals support metabolism throughout
b-selection (Ciofani and Zuniga-Pflucker, 2005) and the failed
development of PDK1-null cells could thus reflect defective
trophic responses to Notch. A number of facts are consistent
with this hypothesis: deletion of floxed Notch1 alleles via Cre
excision blocks thymocyte development at the same stage as
PDK1 deletion (Wolfer et al, 2002); Notch-ligand interactions
in pre-T cells activate the PDK1 substrate PKB (Ciofani and
Zuniga-Pflucker, 2005); expression of a constitutively active
PKB mutant can partially substitute for Notch and maintain
thymocyte metabolism during b-selection (Ciofani and
Zuniga-Pflucker, 2005); and PKB serine kinases are required
for the transition of DN thymocytes to the DP stage, partly by
enhancing the proliferation and survival of cells undergoing
b-selection (Mao et al, 2007). A key question then is whether
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the impact of PDK1 loss on thymocyte development stems
only from its key role in regulating PKB and/or reflects the
unresponsiveness of cells to Notch-induced trophic signals.
To address these issues, the present study compares the
development of wild–type (WT) and PDK1-null T cell pro-
genitors in an in vitro model that uses OP9 stromal cells
expressing the Notch ligand delta-like 1 (OP9-DL1 cells) to
drive thymocyte differentiation (Schmitt et al, 2004b; Schmitt
and Zuniga-Pflucker, 2006). To determine the contribution of
the PDK1/PKB pathway to thymocyte development, we stu-
died the differentiation of thymocytes whose WT PDK1 allele
were substituted with a PDK1 L155E mutant, that permits
phosphorylation of PKB, but not other substrates such
as S6K1, PKC, SGK or RSK (Collins et al, 2003, 2005).
The substitution of leucine (L) 155 in PDK1 with glutamate
(E) disrupts the integrity of an important PDK1 domain termed
the PIF-binding pocket. This domain is not required for PKB
phosphorylation, but is necessary for PDK1 to interact with
carboxy-terminal hydrophobic motifs in substrates such as
S6K1 and RSK (Biondi et al, 2000, 2001; Frodin et al, 2000,
2002). The PDK1 L155E mutant can thus support normal
activation of PKB, but not S6K1 and RSK activity (Collins
et al, 2003). The value of PDK1 L155E in dissecting the
contribution of different PDK1 substrates has been demon-
strated in vivo (Collins et al, 2003; Bayascas et al, 2006).
It can substitute for WT PDK1 in insulin responses in skeletal
muscle demonstrating that PKB is the relevant target for
PDK1 in these cells (Bayascas et al, 2006). However, PDK1
L155E does not support normal murine embryo development,
indicating that PDK1 activation of PKB is not sufficient for all
PDK1 functions (McManus et al, 2004).
The present results show that PDK1-null pre-Tcells cannot
respond to Notch-induced trophic signals, because Notch
signals via PDK1 to induce and sustain expression of key
nutrient receptors. In the absence of PDK1, pre-T cells are
blocked at the DN stage of thymocyte differentiation.
Expression of PDK1 L155E, which supports activation of
PKB is able to replace WT PDK1 and restore nutrient receptor
expression and pre-T cell differentiation, but does not restore
normal thymus cellularity. These results identify an impor-
tant role for the PDK1/PKB pathway during thymocyte differ-
entiation, but show that the importance of PDK1 in the
thymus cannot be ascribed solely to its role upstream of
PKB. T cell development is thus equally dependent on PDK1
substrates that interact with PDK1 via its PIF domain.
Results
PDK1-deficient pre-T cells cannot respond to Notch
signals and have defective expression of key nutrient
receptors
To assess whether PDK1 is required for Notch-induced thymo-
cyte growth, differentiation and proliferation, we com-
pared the responses of WT versus PDK1-null pre-T cells in
an in vitro system using OP9 stromal cells expressing the
OP9-DL1. The OP9-DL1 system allows an assessment of
Notch responsiveness in pre-T cells in vitro (Schmitt and
Zuniga-Pflucker, 2002; Zuniga-Pflucker, 2004). PDK1-null pre-T
cells were obtained from PDK1flDneo/flDneo Lck-Creþ mice (here-
after referred to as T-PDK1/ mice), which were generated
by crossing mice with floxed PDK1 exons 3 and 4 on both
alleles (PDK1flDneo/flDneo) (Lawlor et al, 2002) with mice
expressing Cre recombinase under the control of the proximal
p56lck proximal promoter (Lck-Creþ ), which induces Cre
expression in DN T cell progenitors in the thymus
(Takahama et al, 1998; Hinton et al, 2004). DN thymocytes
can be subdivided on the basis of differential surface expres-
sion of CD44 and CD25: the first T cell progenitors are
CD44þ/CD25 (DN1) followed sequentially by CD44þ/
CD25þ (DN2), CD44/CD25þ (DN3) and CD44/CD25
(DN4) populations. In T-PDK1/, thymocytes are blocked
in development at the DN4 stage (Hinton et al, 2004).
WT DNs cultured on OP9-DL1 cells increase in cell size,
whereas cells cultured on OP9 cells in the absence of DL-1 do
not (Figure 1A). DNs cultured on OP9-DL1 cells also prolif-
erate (70- to 80-fold in 6 days) and differentiate to DP
thymocytes that co-express CD4 and CD8 (Figure 1B). In
contrast, DN thymocytes cultured on OP9 cells in the absence
of Notch ligand do not proliferate, although they differentiate
to DPs (Figure 1B). T-PDK1/ DN thymocytes fail to increase
in cell size in response to OP9-DL1 (Figure 1C) and do not
proliferate or differentiate to DPs (Figure 1D). The small size
of T-PDK1/ DN thymocytes cultured on OP9-DL1 cells
(Figure 1A versus Figure 1C) parallels what is seen in
ex vivo PDK1 deleted pre-T cells (Hinton et al, 2004), which
are small compared to controls (Figure 1E).
PDK1-null pre-T cells thus do not grow, differentiate or
proliferate in response to Notch. We examined whether this
defect could be attributed to defective expression of Notch on
T-PDK1/ DNs. A DL4-IgG fusion protein was used to
monitor Notch1 expression (Besseyrias et al, 2007).
Figure 1F shows that WT and PDK1-null pre-T cells express
Notch1. There is a two-fold reduction in Notch1 expression in
PDK1-null cells, but does not explain failed development of
T-PDK1/ DNs as Notch1 haploinsufficient thymocytes develop
normally (F Radtke, personal communication) and within
WT DN4s, two-fold differences in Notch1 levels had no
impact on cell size (Supplementary Figure 1). Moreover,
PDK1/ DN4s expressing identical levels of surface Notch1
as WT DN4s (Region A in Figure 1F) are still smaller
(Figure 1G).
T lymphocyte cell size is dependent on the regulated
expression of amino-acid transporters that include CD98
(42F) as a key component (Gottesdiener et al, 1988;
Lindsten et al, 1988; Parmacek et al, 1989; Rathmell et al,
2000; Edinger and Thompson, 2002). The upregulation of
CD71, the transferrin receptor, mediates iron uptake and is
also critical for cell growth (Schneider et al, 1982; Trowbridge
and Shackelford, 1986). Therefore, we considered whether
defective growth response of PDK1-null pre-T cells might
result from defective expression of nutrient transporters
during thymus development. In initial experiments, we ex-
plored whether thymocyte differentiation is accompanied by
changes in expression of CD71 and CD98. Figure 2A shows
that DN3 thymocytes express low levels of CD98 and CD71,
whereas surface expression of these nutrient transporters is
high in DN4s. Progression through b-selection is thus accom-
panied by upregulation of CD71 and CD98. We then asked
whether Notch controls CD71 and CD98 expression.
Figure 2B shows that DN3 thymocytes cultured on OP9-DL1
cells upregulate expression of CD71 and CD98, but this does
not happen when they are cultured on OP9 cells in the
absence of Notch signalling. DN3s cultured on OP9-DL1
cells also increase in cell size (Figure 2B). DN4 thymocytes
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have high levels of CD71 and CD98 expression ex vivo
(Figure 2A); they strikingly lose expression of these receptors
if cultured on OP9 cells, but maintain CD71 and CD98
expression if cultured on OP9-DL1 cells (Figure 2C). Hence,
sustained Notch signalling is required to maintain CD98 and
CD71 surface expression on DN4 thymocytes. The cell size of
DN4 thymocytes is also sustained by Notch: DN4s cultured
on OP9 cells rapidly decrease in size, but maintain cell size
when cultured on OP9-DL1 cells (Figure 2C).
Notch1 thus regulates nutrient receptor expression on pre-
T cells, but a key question is whether pre-TCR signalling is
essential for T cells to become competent to respond to
Notch1 in the context of CD98 and CD71 expression. To
address this issue, we cultured DN3 cells from Recombinase
gene 2-null mice (Rag2/) that lack a pre-TCR, on OP9-DL1
cells. Figure 2D shows that Rag2/ DN3s fail to upregulate
CD98 and CD71 when cultured on OP9-DL1 cells. Hence,
Notch is not sufficient to regulate CD71 and CD98 expression
in the absence of the pre-TCR, rather Notch is required
to sustain expression of CD98 and CD71 on b-selected
pre-T cells.
Next, we examined CD71 and CD98 expression in thymo-
cytes from T-PDK1/ mice. In T-PDK1/ mice, there is
partial deletion of PDK1 in DN3s, complete PDK1 loss in
the DN4s and a failure of these cells to develop beyond the
DN4 stage (Hinton et al, 2004). Figure 2E shows that CD98
and CD71 expression levels are defective in PDK1/ DN4
thymocytes. DN4 thymocytes from T-PDK1/ mice were
uniformly low for CD98 expression and had a high frequency
of CD71 low cells compared to WT controls. The loss of CD71
and CD98 expression is not reflective of a global signalling
defect in T-PDK1/ DN4s, because the upregulation of a
number of other surface receptors occurs normally as PDK1-
null DN3s transit to DN4s. T-PDK1/ DN4s can thus upre-
gulate CD2 and CD5 expression normally; a marker of a
functioning pre-TCR (Hinton et al, 2004). The reduced
Figure 1 PDK1 is required for Notch-induced pre-T cell development. (A) Data show analysis of relative cell size (based on flow cytometric
analysis of forward scatter) of G0/G1 thymocytes. WT DN3 thymocytes from were co-cultured for 2 days with OP9 or OP9-DL1 stromal
cell monolayers. (B) Data show surface expression of CD4 and CD8 on thymocytes from WT mice before (input) and after culture on OP9 and
OP9-DL1 for times indicated. DN thymocytes from WT mice were co-cultured for times indicated with OP9 or OP9-DL1. Numbers in brackets
refer to fold proliferation. Numbers in quadrants indicate the percentage of each corresponding population. Data are representative
of three independent experiments. (C) Data show analysis of relative cell size of T-PDK1/ (PDK1flDneo/ Lck-Creþ ) DNs co-cultured
for 2 days with OP9 or OP9-DL1 stromal cells. Data are representative of three independent experiments. (D) Data show CD4 and CD8 staining
of T-PDK1/ DNs following co-culture on OP9-DL1 for times indicated. Numbers in brackets refer to fold proliferation. Numbers in
quadrants indicate the percentage of each corresponding population. Data are representative of three independent experiments. (E) The data
shows analysis of relative cell size, based on flow cytometric analysis of forward scatter, of G0/G1 ex vivo DN4 thymocytes from control
T-PDK1þ /þ (PDK1flDneo/flDneo) and T-PDK1/ (PDK1flDneo/flDneo Lck-Creþ ) mice. Data are representative of three independent experiments.
(F) Data show DL4–IgG fusion protein staining of ex vivo of T-PDK1/ and normal littermate control DN4s. Geometric mean fluorescent
intensities; T-PDK1/¼ 68, T-PDK1þ /þ ¼ 110. Data are representative of two independent experiments. (G) The data show analysis of relative
cell size, based on flow cytometric analysis of forward scatter, of region A (F) gated DN4 thymocytes taken immediately ex vivo from control
T-PDK1þ /þ (PDK1flDneo/flDneo) and T-PDK1/ (PDK1flDneo/flDneo Lck-Creþ ) mice.
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expression of CD98 and CD71 on PDK1-null DN4s reveals that
the expression of these key nutrient receptors is mediated by
PDK1.
Is reduced expression of nutrient receptors sufficient to
explain the defective growth responses of pre-T cells?
Experiments to limit nutrient availability revealed that the
ability of pre-T cells to increase cell size and develop in
response to Notch was dependent on the availability of
exogenous amino acids (data not shown). We also examined
whether differences in levels of expression of nutrient recep-
tors on the surface of pre-T cells had an impact on trophic
responses in pre-T cells. The data (Supplementary Figure 2)
show that WT DN4s expressing low levels of CD71 or CD98
are small cells compared to cells expressing high levels of
CD71. Hence, expression of CD98 and CD71 is rate limiting
for pre-T cell growth.
A PDK1 L155E mutant supports nutrient receptor
expression and pre-T cell differentiation
There are multiple PDK1 substrates in T cells, including PKB,
S6K1 and RSK. Expression of constitutively active PKB mu-
tants can substitute for cytokines and induce expression of
CD71 and CD98 in haematopoietic cells (Edinger and
Thompson, 2002). PDK1 is necessary for PKB activation
and hence the impact of PDK1 loss on thymocyte develop-
ment could reflect loss of PKB activity in these cells. In this
context, simultaneous loss of three PKB isoforms blocks
thymocyte development at the DN/DP stage, similar to the
effects of deleting PDK1 (Hinton et al, 2004; Mao et al, 2007).
However, it is not known if PKB is the only effector of PDK1
in the thymus and it is important to address the involvement
of additional PDK1 substrates in T cell development.
One way to explore the contribution of PKB to PDK1
function is to use ectopically expressed constitutively active
PKB mutants, a strategy used to determine much of what we
know about PKB in T cells (Jones et al, 2000; Parsons et al,
2001; Edinger and Thompson, 2002; Na et al, 2003; Rathmell
et al, 2003; Patra et al, 2004). However, PKB mutants may
not necessarily mimic the actions of endogenous PKB. One
alternative and powerful strategy to explore the relative contribu-
tions of different PDK1 substrates to a biological response
in vivo is to analyse mice with ‘knock-in’ mutations of PDK1
alleles (Collins et al, 2003, 2005; McManus et al, 2004;
Bayascas et al, 2006). One such PDK1 mutant, containing a
L155E mutation, cannot support activation of S6K and RSK
but allows activation of PKB (Collins et al, 2003; Figure 3A).
Figure 2 Nutrient receptor expression is regulated by Notch during thymocyte development and requires PDK1. (A) Data show CD98 and
CD71 expression on WT DN3 and DN4 thymocytes. Data are representative of three independent experiments. (B) Data show CD98 and CD71
expression levels in sorted DN3 WT thymocytes co-cultured on OP9 and OP9-DL1 monolayers for times indicated. Analysis of relative cell size,
based on flow cytometric analysis of forward scatter, is also shown. Data is representative of three independent experiments. (C) Data show
expression of CD98 and CD71 and relative cell size based on flow cytometric analysis of forward scatter for sorted DN4 WT thymocytes
co-cultured on OP9 and OP9-DL1 monolayers for 26 h. Data is representative of three independent experiments. (D) Data show expression of
CD98 and CD71 and relative cell size based on flow cytometric analysis of forward scatter for RAG2/ thymocytes co-cultured on OP9 and
OP9-DL1 monolayers for 26 h. Data are representative of three independent experiments. (E) The data show flow cytometry for CD98 and CD71
surface expression on DN4 (CD25CD44) thymocytes taken immediately ex vivo from T-PDK1/ (PDK1flDneo/flDneo Lck-Creþ ) or WT mice.
Data is representative of two independent experiments.
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Mice that are homozygous for the PDK1 L155E mutation do
not survive beyond developmental stage E12. However, it is
possible to generate thymocytes that selectively express PDK1
L155E (T-PDK1L155E/) by backcrossing mice that express a
single PDK1 L155E allele and a single PDK1 floxed allele
(PDK1L155E/flDneo) with mice expressing Cre recombinase
under the control of the p56lck proximal promoter
(Supplementary Figure 3). The presence of the single PDK1
floxed allele in all tissues allows normal mouse development.
However, as progenitors enter the thymus and express Cre
recombinase, the WT allele is deleted thereby generating
pre-T cells that express a single PDK1 L155E allele
(PDK1L155E/flDneo Lck-Creþ , referred to as T-PDKL155E/).
A comparison of the ability of a single PDK L155E allele versus
a single WT allele to support T cell development can then be
assessed relative to the impact of complete PDK1 deletion.
The crucial control for the analysis of pre-T cells that express
the single L155E mutant allele are pre-T cells that express a
single WT PDK1 allele (PDK1þ /flDneo Lck-Creþ , referred to as
T-PDK1þ /). The impact of PDK1 haplo-insufficiency on
thymocyte development has been described and of relevance
to the present work is the fact that a single WT PDK1 allele
restores DN4 cell size and cell cycle progression and allows
thymocyte differentiation from DNs to DPs (Kelly et al, 2006).
Experiments with PDK1 L155E explore whether kinases
that interact with PDK1 via its PIF domain are required for
thymocyte development. Initially, we compared CD71 and
CD98 expression in DN4 thymocytes from T-PDK1þ / and
T-PDK1L155E/ mice. Figure 3B shows that expression of
PDK1 L155E restores CD71 and CD98 expression to a level
Figure 3 PDK1 L155E restores nutrient receptor expression and thymocyte differentiation. (A) A schematic representation of PDK1 L155E. A
leucine (L) to glutamate (E) mutation at residue 155 in the PIF domain of PDK1 (denoted by *) prevents docking of PDK1 at the H-motif of
substrates S6K, SGK and RSK. This prevents their T loop phosphorylation by PDK1 and subsequent activation. Dotted lines represent these
inactivated pathways. PDK1 L155E mutation is permissive for PKB activation (solid line)(Collins et al, 2003). (B) Data show CD98 (left panel)
and CD71 (right panel) expression on control T-PDK1þ / (PDK1þ /flDneoLck-Creþ ) and T-PDK1L155E/ (PDK1L155E/flDneoLck-Creþ ) DN4
thymocytes. (C) Data show CD44 and CD25 expression on T-PDK1/ (PDK1flDneo/flDneoLck-Creþ ), T-PDK1þ / and T-PDK1L155E/ DNs.
Data are representative of four independent experiments. (D) Flow cytometric analysis of CD4 and CD8 expression on T-PDK1/, T-PDK1þ /
and T-PDK1L155E/ Thy1þ thymocytes is shown. Data are representative of four independent experiments. (E) Data show TCRb staining
of Thy1-gated T-PDK1þ / and T-PDK1L155E/ thymocytes (F) Data shows intracellular staining for phosphorylated S6 ribosomal protein in
T-PDK1þ / and T-PDK1L155E/ DN4s. Data show phospho S6 staining in thymocytes immediately ex vivo (filled histogram) or treated with
20 nM rapamycin (open histogram) as an internal negative control to reduce S6 protein phosphorylation to basal levels. Data are representative
of three independent experiments. (G) Data show western blot analysis of phosphoGSK3 a/b Ser21/9 and S6 ribosomal protein Ser235/6 in
wild type (WT), T-PDK1L155E/ (L155E) and T-PDK1/ DN3 and DN4 thymocytes.
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comparable to that seen in DN4s expressing WT PDK1.
PDK1 L155E could also restore thymocyte differentiation in
PDK1 null pre-T cells. The distribution of the different DN
subpopulations in T-PDK1þ / and T-PDK1L155E/ mice was
comparable (Figure 3C). Figure 3D shows that unlike
T-PDK1/ thymi, which have virtually no DPs and single
positives (SPs), T-PDK1L155E/ thymi contain DP and SP
subsets at relatively normal ratios. Mature WT SP thymocytes
express high surface levels of the TCRb and there was a
normal frequency of these cells in T-PDKL155E/ thymi
(Figure 3E). PDK1 L155E can thus substitute for PDK1 loss
and is sufficient for normal CD71 and CD98 expression and
for pre-T cell differentiation into DPs and SPs.
A genomic PCR analysis verified that Cre-mediated dele-
tion of the flDneo allele had occurred in T-PDKL155E/ DPs
(Supplementary Figure 4). There was also functional loss of
PDK1 as judged by failed phosphorylation of the ribosomal
S6 subunit in T-PDK1L155E/DN4 thymocytes. S6 phosphor-
ylation is mediated by S6K1, which requires phosphorylation
at its ‘T loop’ site by PDK1. A crucial step that enables this
phosphorylation event is the docking of PDK1 via its PIF
domain at a hydrophobic-motif in S6K. The L155E mutant of
PDK1 is thus defective in activating S6K1 (Collins et al, 2003).
The activity of S6K1 can be monitored by quantification
of phosphorylation of its substrate, the ribosomal S6 subunit,
by intracellular staining with specific phosphorylated S6
antisera. Basal levels of S6 phosphorylation are high in
WT DN4s, but absent following PDK1 deletion (Hinton
et al, 2004). Figure 3F shows that expression of a single
WT PDK1 allele can support activation of S6K1 in pre-T cells,
but the PDK1 L155E allele cannot. These data were confirmed
by western blot analysis (Figure 3G). Western blot data
also confirm that PDK1 L155E can support PKB activity
as determined by the normal phosphorylation of GSK3a
on its PKB substrate sequence Serine 21 in both WT
and PDK1 L155E pre-T cells (Figure 3G). In contrast,
GSK3a Serine 21 phosphorylation is absent in PDK1-null
pre-T cells.
PDK1 L155E is not sufficient for cell growth
or proliferation of pre-T cells
PDK1 L155E substitutes for WT PDK1 in the context of CD98
and CD71 expression and DN to DP differentiation. However,
DN to DP transition is normally accompanied by a large
proliferative expansion of b-selected pre-T cells and there
was no such proliferative expansion in T-PDK1L155E/ mice
(Figure 4A). T-PDK1L155E/ mice thus have very low numbers
of DPs and SPs and peripheral a/b Tcells compared to control
mice (Figure 4B). PDK1 L155E thus supports DN to DP
differentiation, but does not restore thymus cellularity. In
accordance with the failed proliferative expansion of
T-PDK1L155E/ thymocytes, there was a decrease in the
frequency of cells in S/G2 phases of the cell cycle in
T-PDK1L155E/ DN4s (Figure 4C). Moreover, the normal in-
crease in cell size that accompanies the DN3 to DN4 transi-
tion is lost in T-PDK1L155E/ mice (Figure 4D). Hence,
expression of a single WT PDK1 allele can maintain normal
growth and proliferation of pre-T cells, whereas PDK1 L155E
cannot. Thus, PDK1 activation of PKB is sufficient for pre-T
cell differentiation, but PDK1 substrates that interact with
PDK1 via its PIF domain are required for optimal pre-T cell
growth and proliferative expansion.
Notch-induced proliferation but not differentiation
of T cell progenitors is mTOR and RSK dependent
The PDK1 PIF domain is required for the phosphorylation of
multiple kinases, such as RSK and S6K1 (Collins et al, 2003).
We examined the role of RSK in pre-T cell development using
a recently described specific RSK inhibitor BI-D1870 (Sapkota
et al, 2007). This inhibitor inhibits all four RSK isoforms, but
not other related AGC kinases (Sapkota et al, 2007). Figure 5A
shows that RSK inhibition does not prevent the DN to DP
Figure 4 PDK1 L155E does not restore thymus cellularity. (A) Data show T-PDK1þ / (PDK1þ /flDneoLck-Creþ ) and T-PDK1L155E/ (PDK1L155E/
flDneoLck-Creþ ) thymocyte subpopulation numbers. For DN thymocytes; T-PDK1þ / (n¼ 4) and T-PDK1L155E/ (n¼ 3) mice, for DP
thymocytes; T-PDK1þ / (n¼ 4) and T-PDK1L155E/ (n¼ 8) mice, for SP thymocytes; T-PDK1þ / (n¼ 4) and T-PDK1L155E/ (n¼ 6) mice.
(B) Data show numbers of a/b T cells from T-PDK1þ / and T-PDK1L155E/ mice. (C) Data show the percentage of cells in the proliferative
(S and G2) stages of the cell cycle in T-PDK1þ / (n¼ 4) and T-PDK1L155E/ (n¼ 4) DN3 and DN4 cells. (**P-value of significance 0.0074).
(D) Data show analysis of relative cell size based on flow cytometric analysis of forward scatter for T-PDK1þ / and T-PDK1L155E/ DN3 and
DN4 thymocytes. Data are representative of four independent experiments.
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differentiation of WT pre-T cells, but does inhibit Notch-
induced proliferative expansion of these pre-T cell subpopu-
lations (Figure 5B). Inhibition of RSK with BI-D1870 thus
allows cells to differentiate, but does not allow them to
proliferate normally. We also considered the possible con-
tribution of S6K1 to thymus development. S6K1 must be
phosphorylated by PDK1 at its T loop site to become acti-
vated, but also has an additional requirement for PDK1
function as its activation is dependent on PKB, which reg-
ulates S6K1 via modulation of TSC-1/2 function and mTOR
(mammalian target of rapamycin) (Inoki et al, 2002; Jaeschke
et al, 2002; Manning et al, 2002). In this respect, in mature
T cells, S6K1 couples PKB and mTOR to the control of T cell
cycle progression (Brennan et al, 1999).
Previous studies have shown that inhibition of mTOR with
rapamycin reduces thymus cellularity in vivo (Chiang and
Abraham, 2005; Holz et al, 2005). Figure 5C and D show that
rapamycin blocks Notch-dependent proliferative expansion
of pre-T cells in vitro, but not DN to DP differentiation. As
rapamycin immediately inactivates S6K1, these results are
consistent with a role for S6K1 in thymus development.
However, important caveats are that rapamycin can disrupt
sustained activation of PKB (Sarbassov et al, 2006).
Moreover, mTOR is needed for PKB activation of S6K1, but
can also regulate S6K1-independent pathways (Dann and
Thomas, 2006). Accordingly, the ability of rapamycin to
inhibit Tcell proliferation may be explained by a requirement
for mTOR signalling to mediate PKB function, rather than
reflecting loss of S6K1 activity. In this context, in a pro-B cell
line, PKB could induce expression of CD98 and CD71 via a
mTOR-dependent pathway (Edinger and Thompson, 2002).
To explore the mTOR requirement for nutrient receptor
expression in pre-T cells, we examined the impact of rapa-
mycin on CD98 and CD71 expression in the OP9 DL-1 system.
The data (Figure 5E) show that the ability of Notch signals
to sustain expression of CD98 and CD71 is partially
sensitive to rapamycin inhibition. Hence, the expression of
nutrient receptors in pre-T cells is regulated by PDK1- and
mTOR-sensitive pathways.
Discussion
The differentiation and proliferation of pre-T cells in the
thymus is dependent on sustained Notch receptor/ligand
interactions (Schmitt and Zuniga-Pflucker, 2005; Guidos,
2006; Visan et al, 2006). The present work shows that
Notch-mediated trophic and proliferative responses are lost
following deletion of PDK1. As T cell progenitors progress
through b-selection, there is induced cell surface expression
of CD98, an essential subunit of mammalian L-type amino-
acid transporters and CD71, the transferrin receptor.
The expression of these nutrient receptors is induced by the
Figure 5 Inhibition of either mTOR or RSK permits thymocyte differentiation but not proliferation. (A) The data show surface expression of
CD4 and CD8 on DN WT thymocytes following 3 days co-culture with 5 ng/ml IL7 on OP9-DL1 monolayers in the presence or absence of 10mM
BI-D1870. The data are representative of two independent experiments. (B) Data show numbers of cells following 6 days co-culture of DN
thymocytes on OP9-DL1 in the presence of BI-D1870 at concentrations indicated. (C) Data show the number of cells following 6 days co-culture
of DN thymocytes co-cultured on OP9-DL1 monolayers with 5 ng/ml IL7 in the presence or absence of 20 nM rapamycin. Data are
representative of three independent experiments. (D) Data show CD4 and CD8 expression on DN3 WT thymocytes following 6 days co-
culture with 5 ng/ml IL7 on OP9-DL1 in the presence or absence of 20 nM rapamycin. Data are representative of three independent experiments.
(E) Data show CD98 (left panel) and CD71 (right panel) surface expression on DN3 thymocytes, following 2 days co-culture with 20 nM
rapamycin on OP9-DL1. Data are representative of three independent experiments.
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pre-TCR in a Notch- and PDK1-dependent manner. Moreover,
sustained Notch signalling is required to maintain CD71 and
CD98 expression as pre-T cells progress through b-selection.
Strikingly, PDK1 deletion prevents expression of these key
nutrient receptors and prevents Notch-induced growth
responses. The observations that PDK1 regulates the expres-
sion of key amino-acid and iron transporters during
thymocyte development and is required for Notch trophic
responses offer an explanation as to why the loss of PDK1 has
such a major impact on T cell development. The loss of
nutrient receptor regulation in PDK1-null T cells will thus
render the cells metabolically insufficient to support the
demands made by the massive proliferative expansion occur-
ring as thymocytes make the DN to DP transition.
To investigate PDK1 substrates that control expression of
CD98 and CD71, we looked at the expression of these nutrient
receptors in pre-T cells expressing a PDK1 L155E allele that
can activate PKB, but not AGC kinases that bind to PDK1 via
its PIF domain. PDK1 L155E restores expression of CD71 and
CD98 and also supports both the differentiation of pre-T cells
to DP and mature SP cells. PKB thus has key functions
regulating the expression of amino-acid transporters and
transferrin receptors during thymocyte development.
However, PDK1 L155E did not restore normal thymus cellu-
larity. Hence, PKB activation is sufficient for thymocyte
differentiation, but not sufficient for optimal proliferation.
Accordingly, kinases that interact with PDK1 via its PIF
domain are necessary for cell growth and proliferation of
pre-Tcells in the thymus. The role of PDK1 during thymocyte
development is thus multifaceted and not simply a reflection
of its role as an upstream activator of PKB.
Serine/threonine kinases that interact with PDK1 via its
PIF domain include RSK and S6K1. The present results
identify RSK as an important signalling molecule for pre-T
cell development, as inhibition of this kinase inhibited pro-
liferative expansion of pre-T cells, but did not prevent their
differentiation. The importance of the PDK1 PIF domain
could thus be explained by its role in RSK regulation.
However, there is still the question of the involvement of
S6K1. It is difficult to assess a thymus autonomous role for
S6Ks in mice doubly deficient for S6Ks, as these show
perinatal lethality (Pende et al, 2004). Nevertheless, we tested
the role of another S6K regulator mTOR in thymocyte growth
and proliferation by examining the impact of rapamycin on
Notch-induced thymocyte development. These experiments
revealed that the inhibition of mTOR with rapamycin pre-
vents optimal nutrient receptor expression and growth and
proliferation of DN thymocytes, but permits their differentia-
tion. Accordingly, there is a dual requirement for PDK1 and
mTOR for cell growth and proliferation during thymocyte
development.
In summary, the present study shows that PDK1 is im-
portant during thymocyte development, because it regulates
expression of key nutrient receptors on the surface of pre-T
cells and mediates Notch-induced cell growth and prolifera-
tive responses. PDK1 was first identified as a key activator of
PKB, but was also found to mediate activation of other AGC
kinases such as RSK and S6K1 (Biondi et al, 2000, 2001;
Frodin et al, 2000, 2002). A PDK1 L155E mutant, with a
disrupted PIF pocket can support normal activation of PKB
and restore nutrient receptor expression and DP and SP
thymocyte differentiation in PDK1-null cells. However,
PDK1 L155E cannot support normal thymocyte proliferation.
The importance of PDK1 for b-selection thus reflects the role
of multiple AGC serine kinases in this process rather than just
reflecting PKB regulation.
Materials and methods
Mice
Mice (5- to 7-week-old) (backcrossed for at least seven generations
to C57BL6) were maintained in SPF conditions under Home Office
project license PPL60/3116. T-PDK1/ mice (PDK1flDneo/flDneo
Lck-Creþ or PDK1flDneo/ Lck-Creþ were generated as described
previously (Takahama et al, 1998; Lawlor et al, 2002; Hinton et al,
2004). T-PDK1/ mice have partial deletion of PDK1 in DN3
thymocytes and complete ablation of PDK1 in DN4 pre-T cells
(Hinton et al, 2004). Control mice used for analyses of T-PDK1/
mice were age-matched WT littermates or PDK1flDneo/flDneo where
indicated.
Mice containing a knock-in mutation of PDK1, wherein leucine
(L) at residue 155 was changed to glutamate (E) (PDK1L155E/þ )
(Collins et al, 2003) were crossed with PDK1flDneo/flDneo mice to
generate mice expressing a single PDK1 L155E allele and a single
PDK1 floxed allele (PDK1L155E/flDneo). These were then backcrossed
with mice expressing Cre recombinase under the control of the
p56lck proximal promoter in Tcell precursors to generate PDK1L155E/
flDneo Lck-Creþ mice (referred to as T-PDK1L155E/). Control mice
PDK1þ /flDneo Lck-Creþ (referred to as T-PDKþ /) were generated
by crossing mice expressing a single PDK1 floxed allele (PDK1þ /flDneo)
with mice expressing Cre recombinase under the control of the
p56lck proximal promoter.
PCR analysis
Cre-mediated deletion of the floxed PDK1 allele from DP sorted
thymocytes in T-PDK1L155E/ mice was confirmed by PCR using
primers p99 (50-ATC CCA AGT TAC TGA GTT GTG TTG GAA G) and
p100 (50-TGT GGA CAA ACA GCA ATG AAC ATA CAC GC). A PCR
product of 200 bp was generated for WTand PIF alleles and a 250 bp
band was generated when the flDneo allele was present. A 200 bp
product generated by PCR analysis using primers p80 (50-CTA TGC
TGT GTT ACT TCT TGG AGC ACA G) and p100 was indicative of
deletion of exons 3 and 4 of PDK1.
Flow cytometric analysis
Antibodies conjugated to fluorescein isothiocyanate, phycoerythrin,
allophycocyanin and biotin were obtained from either Pharmingen
(San Diego, CA, USA) or eBioscience (San Diego, CA, USA).
TriColour-conjugated antibodies were obtained from Caltag
(Burlingame, CA, USA). Cells were stained for surface expression
of the following markers using the antibodies in parentheses: CD4
(RM4-5), CD8 (53-6.7), CD25 (7D4), CD44 (IM7), CD71 (C2), CD98
(RL388), Thy1.2 (53-2.1), TCR b (H57-597), B220 (RA3-6B2) and
TCR g/d (GL3). Cells were stained with saturating concentrations of
antibody in accordance with the manufacturer’s instructions. Data
were acquired on either a FACS Calibur (Becton Dickinson, Franklin
Lakes, NJ, USA) or an LSR1 flow cytometer (Becton Dickinson)
using CellQuest software and were analysed using either CellQuest
(Becton Dickinson) or FlowJo (Treestar, San Carlos, CA, USA)
software. Viable cells were gated according to their forward scatter
and side scatter profiles. CD4 and CD8 DN subsets were gated by
lineage exclusion (lineage) of all CD4, CD8 DP and SP cells and
TCR g/d. DN3s and DN4s were further defined as CD25þCD44 and
CD25CD44 thymocytes, respectively. Mature SP thymocytes were
defined as Thy-1þ , TCRbhi and positive for CD4 or CD8 expression.
A DL4 IgG fusion protein was used to monitor Notch1 expression as
described previously (Besseyrias et al, 2007). Cellular DNA content
was measured by DAPI staining of saponin permeabilised cells.
Phospho-S6 levels in ex vivo thymocytes was assessed as described
previously (Hinton et al, 2004).
OP9 cultures and assay
OP9 bone marrow stromal cells expressing OP9-DL1 (Schmitt et al,
2004b) and control OP9 cells were a gift from Juan Carlos Zu´n˜iga-
Pflu¨cker (Toronto, Canada). OP9 cells were maintained in aMEM
supplemented with 50 mM 2-mercaptoethanol, 100 U/ml penicillin,
1 mg/ml streptomycin and 20% heat-inactivated FBS. Sorted
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thymus DN3 (CD25þCD44) and DN4 (CD25CD44) subsets were
co-cultured on OP9 and OP9-DL1 monolayers for times indicated in
Figure legends. DN3 and DN4 thymocytes were purified by first
depleting thymic populations of CD4þ and CD8þ cells using an
AutoMACs magnetic cell sorter (Miltenyi Biotech, Auburn, CA,
USA) before sorting to a purity greater than 95%, using a FACS
VantageSE cell sorter (Becton Dickinson). On day of harvest
thymocytes were filtered through 50 mm filters to remove OP9 cells
before developmental progression of T lineage cells was assessed.
Western blot analysis
Sorted DN3 and DN4 thymocytes were lysed on ice in NP-40 lysis
buffer (50 mM Hepes (pH 7.4), 75 mM NaCl, 1% Nonidet P-40,
10 mM sodium fluoride, 10 mM iodoacetimide, 1 mM EDTA, 40 mM
b-glycerophosphate, protease inhibitors, 1 mM phenylmethylsulfo-
nyl fluoride, 100mM sodium orthovanadate). Lysates were centri-
fuged at 1600 g for 15 min at 41C. Protein samples were separated by
sodium dodecyl sulphate 4–12% polyacrylamide gel electrophor-
eisis, transferred to nitrocellulose membrane and detected by
western blot analysis using standard techniques. Blots were probed
with antibodies that recognise phosphorylated GSK3 a/b on Ser21/9
(Cell Signaling Technologies, Danvers, MA, USA), total GSK3 a/b
(Upstate, Hampshire, UK), phosphorylated S6 ribosomal protein on
Ser235/236 (Cell Signaling Technologies) and total S6 ribosomal
protein (Cell Signaling Technologies).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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